Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
EGFR | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 9.88E3 | Evidence | |||||
EGFR | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 8.52E3 | Evidence | |||||
EGFR | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 4.98E3 | Evidence | |||||
EGFR | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 200.0 | Evidence | |||||
EGFR | NCK2 | NCK2: Cytoplasmic protein NCK2 | 200.0 | Evidence | |||||
EGFR | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 200.0 | Evidence | |||||
EGFR | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 200.0 | Evidence | |||||
EGFR | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 200.0 | Evidence | |||||
EGFR | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 200.0 | Evidence | |||||
EGFR | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 125.0 | Evidence | |||||
EGFR | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 121.0 | Evidence | |||||
EGFR | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 121.0 | Evidence | |||||
EGFR | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 121.0 | Evidence | |||||
EGFR | CRKL | CRKL: Crk-like protein | 121.0 | Evidence | |||||
EGFR | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 117.0 | Evidence | |||||
EGFR | STAT3 | 117.0 | Evidence | ||||||
EGFR | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 117.0 | Evidence | |||||
EGFR | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 110.0 | Evidence | |||||
EGFR | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 110.0 | Evidence | |||||
EGFR | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 89.20 | Evidence | |||||
EGFR | BMX | N/A | 89.20 | Evidence | |||||
EGFR | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 89.20 | Evidence | |||||
EGFR | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 89.20 | Evidence | |||||
EGFR | LYN | LYN: Tyrosine-protein kinase Lyn | 89.20 | Evidence | |||||
EGFR | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 89.20 | Evidence | |||||
EGFR | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 79.90 | Evidence | |||||
EGFR | SYK | SYK: Tyrosine-protein kinase SYK | 79.90 | Evidence | |||||
EGFR | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 79.90 | Evidence | |||||
EGFR | HCK | N/A | 79.90 | Evidence | |||||
EGFR | JAK1 | 79.90 | Evidence | ||||||
EGFR | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 67.1 | Evidence | |||||
EGFR | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 64.40 | Evidence | |||||
EGFR | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 44.00 | Evidence | |||||
EGFR | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 40.60 | Evidence | |||||
EGFR | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 33.90 | Evidence | |||||
EGFR | INSR | INSR: Insulin receptor precursor | 33.90 | Evidence | |||||
EGFR | KIT | KIT: Mast/stem cell growth factor receptor precursor | 33.90 | Evidence | |||||
EGFR | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 33.90 | Evidence | |||||
EGFR | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 30.10 | Evidence | |||||
EGFR | GRAP | GRAP: GRB2-related adapter protein | 23.20 | Evidence | |||||
EGFR | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 20.50 | Evidence | |||||
EGFR | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 20.50 | Evidence | |||||
EGFR | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 20.50 | Evidence | |||||
EGFR | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 19.70 | Evidence | |||||
EGFR | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 19.70 | Evidence | |||||
EGFR | TGFA | TGFA: Protransforming growth factor alpha precursor [Contains: Transforming grow | 19.70 | Evidence | |||||
EGFR | EGF | EGF: Pro-epidermal growth factor precursor | 19.70 | Evidence | |||||
EGFR | ICAM3 | ICAM3: Intercellular adhesion molecule 3 precursor | 19.70 | Evidence | |||||
EGFR | ITGB4 | N/A | 19.70 | Evidence | |||||
EGFR | BTC | BTC: Probetacellulin precursor [Contains: Betacellulin | 19.70 | Evidence | |||||
EGFR | HLA-A | HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor | 19.70 | Evidence | |||||
EGFR | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 17.60 | Evidence | |||||
EGFR | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 17.60 | Evidence | |||||
EGFR | JAG2 | JAG2: Jagged-2 precursor | 17.60 | Evidence | |||||
EGFR | EPOR | EPOR: Erythropoietin receptor precursor | 15.00 | Evidence | |||||
EGFR | GHR | GHR: Growth hormone receptor precursor | 15.00 | Evidence | |||||
EGFR | IQGAP1 | IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 | 13.50 | Evidence | |||||
EGFR | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 13.50 | Evidence | |||||
EGFR | STAM2 | STAM2: Signal transducing adapter molecule 2 | 13.50 | Evidence | |||||
EGFR | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 13.00 | Evidence | |||||
EGFR | MT2A | MT2A, CES1, MT2: Metallothionein-2 | 13.00 | Evidence | |||||
EGFR | VASP | VASP: Vasodilator-stimulated phosphoprotein | 13.00 | Evidence | |||||
EGFR | NF2 | NF2, SCH: Merlin | 13.00 | Evidence |